semaglutide hypertension Frailty and Effects of in Obesity-Related HFpEF: Findings From the STEP-HFpEF Program Randomized Trial of Effect of

75 Nonetheless, a subset of patients with coexisting obesity and hypertension may still derive benefit from modest BP reductions achieved with GLP-1 RAs

Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion

Approximately 180 kcal

[Google Scholar] 92.Hoosein NM, Gurd RS

Many people living with obesity also face weight stigma from others, which on its own raises the risk of depression

What the Evidence Supports for Lean Mass Preservation The good news is that the muscle loss associated with GLP-1 therapy is modifiable